B.Pharmacy 4th Semester- Pharmacology- Unit 01 and 02- https://www.youtube.com/watch?v=d44onkttxTc&list=PLtEqsPSBZlXuwf74dIoGzz6cLLkoWiEjR
B.Pharmacy 4th Semester- Pharmacology- Unit- 03- https://www.youtube.com/watch?v=xhawgAdtgQM&list=PLtEqsPSBZlXu_UkZF1sdE341ebm7G-xsN
Important terms and definition in ANS- https://drive.google.com/open?id=1xlL4O6-HX09QIq1Uy4TdhbvyPHpGFhD9
200 words and their definition in Pharmacology- https://drive.google.com/open?id=1dGOm-iixB3jxlive9u66J6-2elKJ2Qn2
Myasthenia gravis (MG) is a long-term neuromuscular disease that leads to varying degrees of skeletal muscle weakness. The most commonly affected muscles are those of the eyes, face, and swallowing. It can result in double vision, drooping eyelids, trouble talking, and trouble walking. Onset can be sudden. Those affected often have a large thymus or develop a thymoma.
Myasthenia gravis is an autoimmune disease which results from antibodies that block or destroy nicotinic acetylcholine receptors at the junction between the nerve and muscle. This prevents nerve impulses from triggering muscle contractions. Myasthenia gravis is generally treated with medications known as acetylcholinesterase inhibitors such as neostigmine and pyridostigmine. Immunosuppressants, such as prednisone or azathioprine, may also be used. The surgical removal of the thymus may improve symptoms in certain cases. Plasmapheresis and high dose intravenous immunoglobulin may be used during sudden flares of the condition. If the breathing muscles become significantly weak, mechanical ventilation may be required.